| Trial ID: | L4122 |
| Source ID: | NCT02563834
|
| Associated Drug: |
Thiapalmitate Tracer
|
| Title: |
A Novel Positron Emission Tomography (PET) Approach to Measuring Myocardial Metabolism
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT02563834/results
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: thiapalmitate tracer|DRUG: Saline|DRUG: Insulin
|
| Outcome Measures: |
Primary: Myocardial Fatty Acid Uptake Rate, PET measure of fatty acid uptake rate, 4 Hours | Secondary: Myocardial Oxidation Rate, PET measure of total oxidation rate, 4 Hours|Myocardial Perfusion Rate, PET measure of total myocardial perfusion (blood flow), 4 Hours
|
| Sponsor/Collaborators: |
Sponsor: Indiana University | Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
|
| Enrollment: |
18
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2007-01
|
| Completion Date: |
2009-06
|
| Results First Posted: |
2016-08-31
|
| Last Update Posted: |
2016-08-31
|
| Locations: |
Indiana University Hospital GCRC, Indianapolis, Indiana, 46202, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02563834
|
